ANIP Ani Pharmaceuticals Inc

$79.40 -1.34%

Healthcare · Pharmaceutical Preparations

Ani Pharmaceuticals Inc (ANIP) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.7 billion. Shares last traded at $79.40, 20.2% below their 52-week high. Over the past year the stock is up 25.2%. ANIP trades at a price-to-earnings ratio of 21.29, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 8.8%, above the peer median of -0.1%. Revenue grew 43.8% year over year.

Market Cap

$1.7B

Shares Out

20.9M

EPS (TTM)

$5.17

P/E Ratio

15.36

P/S Ratio

1.88

P/B Ratio

2.95

Dividend / Share

—

Dividend Yield

—

52-Week High

$99.44

52-Week Low

$62.71

Volume

8,448

Avg Vol (3m)

19,694.651

Performance

-2.74%

-1.11%

+6.08%

-1.91%

YTD

+1.27%

+25.22%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.98

SMA (50)

$80.14

SMA (200)

$83.06

Price vs SMA50

-0.92%

Price vs SMA200

-4.40%

ATR (14)

$2.64

Financials

Revenue

$883M

Net Income

$78M

Gross Margin

—

Operating Margin

12.6%

Net Margin

8.8%

Return on Equity

13.9%

Return on Assets

5.5%

Current Ratio

3.12

Debt / Equity

0.51

Revenue Growth (YoY)

+43.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$1.28	2026-05-08
FY 2025	$3.32	2026-02-27
Q3 2025	$2.15	2025-11-07
Q2 2025	$1.05	2025-08-08
Q1 2026	$0.69	2026-05-08
FY 2025	$-1.04	2026-02-27

Full earnings history →

Pharmaceutical Preparations peers

ANIP vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

21.29 / 16.82 med

+27% premium

P/S vs peers

1.88 / 3.54 med

-47% discount

Net margin vs peers

8.8% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.